Renvela, comprimés pelliculés

7680616480019 CH-61648 Tabletten
Renvela, comprimés pelliculés
Renvela, comprimés pelliculés
Renvela, comprimés pelliculés
1 / 3
google

Article details

Package size
180
Selling units
180
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
28/03/2024
Patient information leaflet
Français
28/03/2024
Patient information leaflet
Italien
28/03/2024
Summary of Product Characteristics
Allemand
28/03/2024
Summary of Product Characteristics
Français
28/03/2024
Summary of Product Characteristics
Italien
28/03/2024

Detailed composition

Substance Quantity Type Category
(N/A)
800.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
1.26 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 169.25
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2011

Authorization holder

Sanofi-Aventis (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
61648
Drug name
Renvela, comprimés pelliculés
Galenic form
FILM
ATC Code
V03AE02
Authorization status
Z
Dispensing category
B
First authorization
10/11/2011
Authorization expiration date
31/12/9999
IT Number
07.99.0.
Domain
Human medicine

Package details

Description (FR)
RENVELA cpr pell 800 mg bte 180 pce
Description (DE)
RENVELA Filmtabl 800 mg Ds 180 Stk
Market launch
10/11/2011
Narcotic (BTM)
No

Available generics (1)

Sevelamercarbonate Salmon Pharma, Filmtabletten
GTIN: 7680654010018
CHF 148.45
View